Taiwan - Delayed Quote TWD

Formosan Union Chemical Corp. (1709.TW)

17.70

+0.05

+(0.28%)

At close: 1:30:13 PM GMT+8

Buffett succession, US trade deals, Fed meeting: 3 Things

At Berkshire Hathaway's (BRK-B, BRK-A) annual shareholders meeting over the weekend, chairman and CEO Warren Buffett announced he will be stepping down at the end of the year, to be succeeded by Berkshire Hathaway Energy Chair Greg Abel President Trump has signaled that trade deals over tariffs with other countries could come as early as this week. Federal Reserve officials will be convening in Washington, D.C. this week for their May FOMC meeting, starting this Tuesday and concluding on Wednesday, May 7, with the central bank's latest decision on interest rates and a press conference with Chair Jerome Powell. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.

Yahoo Finance Video 8 minutes ago

WBD

BRK-B

NQ=F
Warren Buffett is stepping aside at Berkshire Hathaway. Here's what he thinks happens next.

Warren Buffett outlined years ago what it would take to be the next CEO at Berkshire Hathaway.

Yahoo Finance 57 minutes ago

BRK-B
The three-year returns have been enviable for Axsome Therapeutics (NASDAQ:AXSM) shareholders despite underlying losses increasing

Investing can be hard but the potential fo an individual stock to pay off big time inspires us. But when you hold the...

Simply Wall St. 8 minutes ago

AXSM
Hims & Hers Appoints Global Operations Expert and Amazon Veteran as Chief Operations Officer

SAN FRANCISCO, May 05, 2025--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the appointment of Nader Kabbani as Chief Operations Officer.1 A seasoned executive known for scaling trusted consumer and healthcare logistics businesses, Kabbani will oversee operations as the company expands access to personalized care for millions more individuals.

Business Wire 20 minutes ago

HIMS
Tyson Foods Misses the Mark on Sales

Tyson Foods reported strong earnings for the latest quarter, but sales failed to meet expectations, showing nearly no growth compared with a year before. On Monday morning, Tyson reported 92 cents in adjusted earnings for its second fiscal quarter, which ended on March 29. With the exception of chicken, a winner in the prior quarter as well, sales volume in all segments fell from the year before.

Barrons.com 28 minutes ago

TSN
These Stocks Are Moving the Most Today: Berkshire Hathaway, Microsoft, Apple, Netflix, Palantir, Tyson Foods, and More

Berkshire Hathaway’s Class B shares fall after Warren Buffett says he’ll be stepping down as CEO at the end of the year, Microsoft kicks off Monday as the largest U.S. company by market cap, Netflix falls as President Donald Trump says he authorized a 100% tariff on films produced overseas. Palantir Technologies, meanwhile, is scheduled to report quarterly earnings Monday.

Barrons.com 44 minutes ago

PLTR

AAPL

MSFT
Cummins Beats Earnings Estimates But Withdraws Full-Year Guidance Due to Tariffs

CEO Jennifer Rumsey cited “growing economic uncertainty driven by tariffs” for withdrawing guidance.

Barrons.com 49 minutes ago

CMI
Berkshire Hathaway (BRK.B) Sits on $300B Cash Pile, Plays the Long Game in Japan

Buffett says no to rushed deals, yes to patience and partnerships

GuruFocus.com 51 minutes ago

BRK-B
Cummins withdraws 2025 financial forecast on tariff woes

"Due to growing economic uncertainty, the company is not providing an outlook for revenue or profitability for the remainder of 2025" Cummins said in its earnings release. The North American trucking market, already dealing with an oversupply of equipment, is now confronted with new challenges arising due to the erratic import tariffs. General Motors pulled its annual forecast earlier this month, days after pausing plans to buy back $2 billion of shares in the first half of the year.

Reuters 1 hour ago

CMI
Tyson Foods Sales Flat on Mixed Volumes

Tyson Foods said sales in its fiscal second quarter were unchanged year-over-year as higher volumes in its chicken business were balanced out by declines in beef and other segments.

The Wall Street Journal 1 hour ago

TSN
ON Semiconductor Stock Climbs on Better-Than-Expected Earnings

FEATURE ON Semiconductor stock climbed in premarket trading Monday after first-quarter earnings and revenue surpassed analysts’ expectations. The Scottsdale, Ariz.-based chip maker posted adjusted earnings of 55 cents a share, beating analysts’ calls for 50 cents, according to FactSet.

Barrons.com 1 hour ago

ON
Berkshire Hathaway (BRK.A) Surges as Buffett Prepares Exit After 60 Years

Greg Abel to succeed Buffett amid record cash pile and market outperformance

GuruFocus.com 1 hour ago

BRK-B
Tyson Foods stock falls as revenue misses estimates

Investing.com -- Tyson Foods, Inc. reported mixed second-quarter results on Monday, with earnings beating expectations but revenue falling short of analyst estimates. The stock dropped 3.9% following the release.

Investing.com 1 hour ago

TSN
TG Therapeutics (TGTX) Lags Q1 Earnings Estimates

TG Therapeutics (TGTX) delivered earnings and revenue surprises of -83.33% and 1.99%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks 1 hour ago

TGTX
ON Semiconductor Corp.: Q1 Earnings Snapshot

SCOTTSDALE, Ariz. AP) — ON Semiconductor Corp. ON) on Monday reported a loss of $486.1 million in its first quarter.

Associated Press Finance 1 hour ago

ON
onsemi Reports First Quarter 2025 Results

SCOTTSDALE, Ariz., May 05, 2025--onsemi (the "Company") (Nasdaq: ON) today announced its first quarter 2025 results with the following highlights:

Business Wire 1 hour ago

ON
Ackman’s Pershing Square to Boost Stake in Howard Hughes Holdings

Howard Hughes Holdings said Bill Ackman’s Pershing Square Capital Management will invest $900 million in the company, boosting its stake further and bringing Ackman back into the fold.

The Wall Street Journal 1 hour ago

HHH
Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)

The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) in all presentations matching the reference product, effective as of April 30, 2025SELARSDI is approved for all indications matching the reference productSELARSDI is indicated for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis in adults and pediatric patients 6 years and older, and the treatment of adult patients with moderately to seve

GlobeNewswire 1 hour ago

TEVA

TEVJF

ALVO
Greg Abel’s Challenge: Lead Berkshire Into a New Era Without the Buffett Touch

Warren Buffett has done what he can to prepare his successor at Berkshire Hathaway. But there is one thing that can’t be simply handed off: the Buffett brand.

The Wall Street Journal 1 hour ago

BRK-B
Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.

Builds upon Firefly’s recent acceptance into the NVIDIA Connect program Marks next major step toward building a proprietary foundation model of the human brain KENMORE, N.Y., May 05, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, is pleased to announce its acquisition of Evoke Neuroscie

GlobeNewswire 1 hour ago

AIFF

Performance Overview

Return	1709.TW	TSEC CAPITALIZATION WEIGHTED ST (^TWII)
YTD	-13.02%	-10.86%
1-Year	-6.90%	+1.00%
3-Year	-21.05%	+22.98%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Formosan Union Chemical Corp. (1709.TW)

Related News

Buffett succession, US trade deals, Fed meeting: 3 Things

Warren Buffett is stepping aside at Berkshire Hathaway. Here's what he thinks happens next.

The three-year returns have been enviable for Axsome Therapeutics (NASDAQ:AXSM) shareholders despite underlying losses increasing

Hims & Hers Appoints Global Operations Expert and Amazon Veteran as Chief Operations Officer

Tyson Foods Misses the Mark on Sales

These Stocks Are Moving the Most Today: Berkshire Hathaway, Microsoft, Apple, Netflix, Palantir, Tyson Foods, and More

Cummins Beats Earnings Estimates But Withdraws Full-Year Guidance Due to Tariffs

Berkshire Hathaway (BRK.B) Sits on $300B Cash Pile, Plays the Long Game in Japan

Cummins withdraws 2025 financial forecast on tariff woes

Tyson Foods Sales Flat on Mixed Volumes

ON Semiconductor Stock Climbs on Better-Than-Expected Earnings

Berkshire Hathaway (BRK.A) Surges as Buffett Prepares Exit After 60 Years

Tyson Foods stock falls as revenue misses estimates

TG Therapeutics (TGTX) Lags Q1 Earnings Estimates

ON Semiconductor Corp.: Q1 Earnings Snapshot

onsemi Reports First Quarter 2025 Results

Ackman’s Pershing Square to Boost Stake in Howard Hughes Holdings

Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)

Greg Abel’s Challenge: Lead Berkshire Into a New Era Without the Buffett Touch

Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.

Performance Overview